CF
CHEESECAKE FACTORY INC (CAKE)·Q3 2025 Earnings Summary
Executive Summary
- Q3 revenue of $907.2M grew 4.8% YoY but declined sequentially; adjusted EPS of $0.68 beat S&P Global consensus by ~8c while revenue came in ~0.6% below estimates, and adjusted EBITDA slightly exceeded consensus; consolidated operating margin was 4.1% and adjusted net income margin ~3.7% (consensus/actual: Revenue $912.6M*/$907.2M, EPS $0.60*/$0.68, EBITDA $64.6M*/$65.5M*)*.
- The Cheesecake Factory comps were +0.3% with pricing ~4% and traffic -2.5%; North Italia comps -3% amid sales transfers and LA fires; Flower Child comps +7% and margin strength; off-premise remained 21% of sales, with delivery ~10% .
- Q4 guidance: revenue $940–$955M, adjusted net income margin ~5.1% implying margin expansion despite softer traffic; FY25 net income margin outlook 4.9% maintained; initial FY26 outlook calls for 4–5% revenue growth, ~5% net income margin, ~26 openings, and $200–$210M capex .
- Liquidity remains strong ($556.5M), debt $644M; dividend of $0.27/share declared and modest buybacks ($1.2M) in Q3; development targets for 2025 (as many as 25 openings) reiterated, including North Italia and Flower Child .
- Potential stock reaction catalysts: EPS/margin beat vs consensus, Q4/FY26 outlook resiliency vs softer industry traffic, and evidence of cost control offsetting beef/medical headwinds .
What Went Well and What Went Wrong
-
What Went Well
- Cheesecake Factory restaurant-level margin expanded 60 bps YoY to 16.3% on labor productivity and wage management; Flower Child comps +7% with adjusted mature-unit margins 17.4% (+140 bps YoY) .
- Adjusted EPS ($0.68) beat consensus ($0.60*) with adjusted EBITDA modestly above consensus ($65.5M* vs $64.6M*) despite a competitive backdrop; cost of sales improved ~80 bps on commodities (ex-beef) (consensus/actual: EPS $0.60*/$0.68; EBITDA $64.6M*/$65.5M*)*.
- Development on track (two FRC openings in Q3; additional FRC post-quarter; two licensed Cheesecake openings in Mexico) with 2025 plan of as many as 25 openings reiterated and an acceleration to ~26 openings in 2026 .
-
What Went Wrong
- Revenue ($907.2M) slightly missed consensus ($912.6M*) and declined sequentially from Q2’s $955.8M; consolidated operating margin compressed to 4.1% from 6.8% in Q2 on deleverage and facility costs .
- Traffic softness industry-wide weighed on comps (Cheesecake traffic -2.5% with ~4% price; North traffic ~-6% with sales transfers and LA fires impact) .
- Q4 headwinds include rising beef (pivot from flattish commodities in Q3 to ~2% in Q4) and ~50 bps YoY labor headwind from group medical; management still expects Q4 adjusted net income margin ~5.1% via cost control .
Financial Results
Segment revenue breakdown
KPIs (Q3 snapshot)
Performance vs S&P Global consensus (Q3 2025)
Values marked with * are retrieved from S&P Global.
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We delivered another quarter of solid results…earnings and profitability finishing above the high end of our expectations…positive comparable sales…underscoring the strength and resilience of our namesake concept.” — David Overton, CEO .
- “The Cheesecake Factory's restaurant-level profit margin increased 60 basis points year over year to 16.3%...margin improvement also realized at North Italia and Flower Child.” — Prepared remarks .
- “Adjusted net income margin of 3.7% exceeded the high end of the guidance we provided.” — CFO .
- “For Q4, we anticipate total revenues to be between $940 million and $955 million…we would anticipate adjusted net income margin to be about 5.1%.” — CFO .
- “Pricing was about 4%…traffic was a negative 2.5%…North Italia price 4%…traffic roughly negative 6%.” — CFO, Q&A .
Q&A Highlights
- Consumer softness and October deceleration: Management attributes incremental caution largely to traffic and potential government shutdown effects (1–2% one-month impact historically) .
- Cost outlook and margins: Commodities flattish in Q3, ~2% inflation in Q4 (beef); ~50 bps YoY labor headwind from group medical in Q4; underlying labor productivity still favorable 10–20 bps; other OpEx +~20 bps from facilities .
- Pricing cadence: Price moderates to ~3.5% in Q4 and ~2% 1H26 effective ~100 bps lower due to mix; positioning vs food-away-from-home inflation mid-3% .
- Segment dynamics: North Italia comps impacted by sales transfer (~2 pts) and LA fires (~1 pt); Flower Child strength continues; Cheesecake bites/bowls improving mix without check dilution .
- Off-premise steady: 21% sales, delivery ~10%, stable vs Q2/LY .
- 2026 setup: 4–5% revenue growth, ~5% net income margin, ~26 openings; capex $200–$210M .
Estimates Context
- Q3 results vs S&P Global consensus: Adjusted EPS $0.68 beat $0.60*; revenue $907.2M missed $912.6M*; EBITDA $65.5M* slightly above $64.6M*. Estimate counts: EPS (18), Revenue (16) .
- Implications: Street likely raises FY25 EPS on margin resilience (Q4 adj. margin ~5.1%, FY25 net income margin 4.9% reiterated) while trimming near-term comp/traffic assumptions and raising Q4 commodity/labor inputs .
Values marked with * are retrieved from S&P Global.
Key Takeaways for Investors
- Margin durability amid softer traffic is the story: EPS beat came from cost control (labor productivity, favorable commodities ex beef), not top-line; Q4 guide implies further margin uplift to ~5.1% adjusted net income margin despite mixed traffic .
- Near-term trading setup: watch October/early Q4 sales cadence, beef cost trajectory, and any resolution of government shutdown risks; management models ~1% traffic step down vs Q3 .
- Concept mix matters: Flower Child outperformance and stable off-premise provide ballast vs North Italia near-term pressures from sales transfer; Cheesecake bites/bowls and loyalty are mitigating check risk without discounting .
- 2026 acceleration: ~26 openings with 4–5% revenue growth and ~5% net income margin frame a path to steady EPS growth once macro stabilizes; capex steps up to $200–$210M to fund pipeline .
- Capital returns supported by strong liquidity: $556.5M available liquidity, dividend maintained at $0.27/share; modest buybacks continue .
- Risks: elevated competitive discounting, beef inflation, group medical variability, and macro-sensitive traffic; management cites resiliency via operational discipline and pricing moderation .
Additional press releases noted: Q3 earnings webcast notice (Oct 7, 2025) and a holiday gift card promotion (Nov 13, 2025) that may support Q4 traffic with a $15 bonus card for $50 gift card purchases .